138 related articles for article (PubMed ID: 11679999)
21. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
[TBL] [Abstract][Full Text] [Related]
22. Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial.
Jaber BL; Zimmerman DL; Teehan GS; Swedko P; Burns K; Meyer KB; Leypoldt JK
Blood Purif; 2004; 22(6):481-9. PubMed ID: 15523174
[TBL] [Abstract][Full Text] [Related]
23. [Nutritional status, comorbidity, and inflammation in hemodialysis].
Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients.
Kaysen GA; Chertow GM; Adhikarla R; Young B; Ronco C; Levin NW
Kidney Int; 2001 Jul; 60(1):333-40. PubMed ID: 11422769
[TBL] [Abstract][Full Text] [Related]
25. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
26. A preliminary study of PDA-based dietary self-monitoring in hemodialysis patients.
Sevick MA; Piraino B; Sereika S; Starrett T; Bender C; Bernardini J; Stark S; Burke LE
J Ren Nutr; 2005 Jul; 15(3):304-11. PubMed ID: 16007560
[TBL] [Abstract][Full Text] [Related]
27. Dialyzer membrane permeability and survival in hemodialysis patients.
Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
[TBL] [Abstract][Full Text] [Related]
28. The deleterious effect of metabolic acidosis on nutritional status of hemodialysis patients.
Soleymanian T; Ghods A
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1149-54. PubMed ID: 22089772
[TBL] [Abstract][Full Text] [Related]
29. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients.
Moretti HD; Johnson AM; Keeling-Hathaway TJ
J Ren Nutr; 2009 Jul; 19(4):298-303. PubMed ID: 19539184
[TBL] [Abstract][Full Text] [Related]
30. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study.
Chan M; Kelly J; Batterham M; Tapsell L
J Ren Nutr; 2012 Nov; 22(6):547-57. PubMed ID: 22406122
[TBL] [Abstract][Full Text] [Related]
31. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
32. Oral essential amino acid supplementation in patients on maintenance hemodialysis.
Phillips ME; Havard J; Howard JP
Clin Nephrol; 1978 Jun; 9(6):241-8. PubMed ID: 668225
[TBL] [Abstract][Full Text] [Related]
33. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
34. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
35. Oral intradialytic nutritional supplement use and mortality in hemodialysis patients.
Weiner DE; Tighiouart H; Ladik V; Meyer KB; Zager PG; Johnson DS
Am J Kidney Dis; 2014 Feb; 63(2):276-85. PubMed ID: 24094606
[TBL] [Abstract][Full Text] [Related]
36. Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients.
Toigo G; Situlin R; Tamaro G; Del Bianco A; Giuliani V; Dardi F; Vianello S; Toffoletto P; Faccini L; Guarnieri G
Kidney Int Suppl; 1989 Nov; 27():S278-81. PubMed ID: 2636671
[TBL] [Abstract][Full Text] [Related]
37. The use of oral essential amino acids in hemodialysis patients.
Laorpatanaskul S; Pochanugool C; Sitprija V
J Med Assoc Thai; 1991 Feb; 74(2):66-70. PubMed ID: 2056260
[TBL] [Abstract][Full Text] [Related]
38. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
[TBL] [Abstract][Full Text] [Related]
40. Increase in BMI over time is associated with fluid overload and signs of wasting in incident peritoneal dialysis patients.
Henriques VT; Martinez EZ; Divino-Filho JC; Pecoits-Filho R; da Costa JA;
J Ren Nutr; 2013 May; 23(3):e51-7. PubMed ID: 23046738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
